SCHEMBL27383632

SCHEMBL27383632

CCc1cc2[nH]c(CNC(=O)C3(C)CC3)cc2cc1F

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ METTL3 Q86U44 6/20 0.37
▸ METTL14 Q9HCE5 6/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HTR2A P28223 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ HTR2B P41595 1/20 0.31
▸ MTNR1A P48039 1/20 0.31
▸ MTNR1B P49286 1/20 0.31
▸ METAP2 P50579 2/20 0.30
▸ BDKRB1 P46663 1/20 0.30
▸ IKBKB O14920 1/20 0.30
▸ RET P07949 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30920444 0.87 RAB9A (0.43) RAB9ANPC1METTL3METTL14SMN1; SMN2
SCHEMBL27247588 0.87 RAB9A (0.38) RAB9ANPC1METTL3METTL14SMN1; SMN2
SCHEMBL27246917 0.87 RAB9A (0.43) RAB9ANPC1METTL3METTL14SMN1; SMN2
SCHEMBL30920136 0.87 RAB9A (0.38) RAB9ANPC1METTL3METTL14SMN1; SMN2
SCHEMBL27384013 0.86 RAB9A (0.39) RAB9ANPC1METTL3METTL14SMN1; SMN2
SCHEMBL27383517 0.86 SMN1; SMN2 (0.42) RAB9ANPC1METTL3METTL14SMN1; SMN2
SCHEMBL30920545 0.86 RAB9A (0.42) RAB9ANPC1METTL3METTL14SMN1; SMN2
SCHEMBL30920207 0.84 RAB9A (0.41) RAB9ANPC1SMN1; SMN2HTR2AHTR2C
SCHEMBL27246962 0.84 RAB9A (0.41) RAB9ANPC1SMN1; SMN2HTR2AHTR2C
SCHEMBL30920135 0.83 RAB9A (0.43) RAB9ANPC1METTL3METTL14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback